New radioactive tracer aims to shine a light on hidden prostate cancer
NCT ID NCT07236112
First seen Nov 19, 2025 · Last updated May 20, 2026 · Updated 21 times
Summary
This early-phase study tests a new radioactive tracer called TRDC002 that helps doctors see prostate cancer cells on a PET scan. It is designed for people whose prostate cancer has come back or spread. The main goal is to find the best dose and timing for clear images, while also checking safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shandong Cancer Hospital
Jinan, Shandong, 250117, China
-
Union Hospital, Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
Conditions
Explore the condition pages connected to this study.